Episode 20: Women's Health Series - Empowering Postpartum Women with Chris Benecchi, Chief Business Officer of Sage TherapeuticsEpisode 20: Women's Health Series - Empowering Postpartum Women with Chris Benecchi, Chief Business Officer of Sage Therapeutics
Healthscape
Chris Benecchi from Sage Therapeutics discusses the launch of Zurzube for postpartum depression and the importance of partnerships in changing women's health.
35:36•8 Jan 2024
Empowering Postpartum Women: Sage's New Treatment
Episode Overview
- Sage Therapeutics launches Zurzube for postpartum depression.
- Addressing stigma in women's health.
- Importance of non-traditional healthcare partnerships.
- Career insights from Chris Benecchi.
- Impact of healthcare innovation on patient lives.
“If you think about therapies, if you think about patient impact, if you think about the development of others, you'll have very successful, very long careers that you can look back with at pride.”
In the latest episode of Kellogg Healthscape, Hannah McGillivray hosts Chris Benecchi, Chief Business Officer at Sage Therapeutics, to discuss Sage's groundbreaking work in treating postpartum depression. The company recently launched Zurzube, the first oral medication designed specifically for women suffering from this condition. This innovative treatment promises to transform the landscape of women's health by addressing a prevalent issue that affects approximately one in eight live births annually in the United States.
Chris Benecchi delves into the challenges and strategies involved in launching Zurzube, emphasizing the importance of overcoming the stigma associated with postpartum depression. He highlights the need for educating healthcare providers and collaborating with non-traditional partners to amplify the impact of such treatments. Benecchi's approach reflects his extensive experience in the biopharmaceutical industry, where he has held various leadership roles at companies such as Alexion, UCB, and Takeda, focusing on global commercial strategy and launch planning.
The discussion also touches on the broader implications of Sage Therapeutics' work, stressing the significance of holistic thinking when addressing brain health disorders. Benecchi shares his insights on career development, encouraging professionals in the field to think beyond products and focus on the disease and patient impact. His career journey, marked by a commitment to innovation and collaboration, offers valuable lessons for listeners interested in pursuing a path in healthcare and biopharma.
Overall, this episode provides an informative and hopeful view into the future of women's health, underscoring the potential of biopharmaceutical innovations to bring about meaningful change. For those interested in further collaboration and learning opportunities, Hannah McGillivray invites engagement with the Kellogg Healthcare Club.
Do you want to link to this podcast?
Get the buttons here!
More From This Show
The latest episodes from the same podcast.
Related Episodes
Similar episodes from other shows in the catalogue.